Boehringer Ingelheim India and National Institute of Pharmaceutical Education and Research (NIPER) Raebareli sign MoU to advance pharmaceutical education and research

Exam-focused facts from the 24 February 2026 current affairs briefing.

Key facts

Boehringer Ingelheim India Private Limited and the National Institute of Pharmaceutical Education and Research (NIPER) Raebareli signed an MoU on 22 Feb 2026 at the Department of Pharmaceuticals, New Delhi.
The MoU covers collaboration in pharmaceutical technologies, novel drug delivery systems, joint research initiatives, academic exchange, and capability-building programmes.
Boehringer Ingelheim will provide NIPER Raebareli access to its open science portal opnMe® to accelerate healthcare innovation.
The partnership will also explore symposia, conferences, short-term courses, and scholar engagement to strengthen scientific exchange.